EU-funded projects

Development of the first in class therapeutic device for use in the treatment of autoimmune neurodegenerative disease
Development of a bispecific antibody fragment for simultaneous cancer control and immune cell recruitment
Development of the first-in-class therapeutic medical device indicated to use during myasthenic crisis in myasthenia gravis patients
Innovative modular PureApta service platform for selection of modified aptamers with diagnostic and therapeutic potential
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.